Related Experiment Video
Updated: Jun 6, 2026

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
Histone and DNA modifications in mental retardation
1Department of Pathology, Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115, USA.
Abstract:
Mental retardation (MR), which affects 1-3% of the total population, refers to a pathological condition whereby the affected individuals suffer from cognitive impairment, which is diagnosed by a low intelligence quotient (IQ) (< 70). Over the years, human genetic studies identified a plethora of candidate genes causing MR, but mechanisms by which these candidates regulate cognitive function remain poorly understood. While the functions of MR genes range from cell signaling and gene expression to synaptic plasticity, there is growing evidence supporting a critical role for epigenetic and chromatin regulatory proteins in MR. Excitingly, recent molecular and genetic studies suggest the possibility of improving cognitive functions via modulation of epigenetic regulators, highlighting a potentially new avenue for therapeutic intervention. In this review, we discuss recent studies on epigenetic regulation in MR and explore the concept of epigenetic therapy for MR.
Insights
Epigenetic regulators play a critical role in cognitive function and intellectual disability (ID). Modulating these epigenetic factors offers a promising new avenue for potential ID therapies.
Area of Science:
- Neuroscience
- Genetics
- Epigenetics
Background:
- Intellectual disability (ID), affecting 1-3% of the population, is characterized by cognitive impairment (IQ < 70).
- Numerous candidate genes for ID have been identified, but their precise roles in cognitive function are not fully understood.
- Emerging evidence highlights the significant involvement of epigenetic and chromatin regulatory proteins in ID.
Purpose of the Study:
- To review recent studies on the role of epigenetic regulation in intellectual disability.
- To explore the potential of epigenetic therapy as a novel therapeutic strategy for ID.
Main Methods:
- Literature review of recent molecular and genetic studies.
- Analysis of research on epigenetic regulators and their impact on cognitive function.
Main Results:
- Epigenetic mechanisms are increasingly recognized as crucial in the pathogenesis of ID.
- Modulation of epigenetic regulators shows potential for improving cognitive functions.
Conclusions:
- Epigenetic dysregulation is a key factor in intellectual disability.
- Epigenetic therapy presents a promising, novel approach for treating ID.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Inheritance of Chromatin Structures
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
